Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects
Identifieur interne : 002419 ( Main/Exploration ); précédent : 002418; suivant : 002420Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects
Auteurs : K. Shannak ; A. Rajput [Canada] ; B. Rozdilsky [Canada] ; S. Kish ; J. Gilbert [Canada] ; O. HornykiewiczSource :
- Brain Research [ 0006-8993 ] ; 1993.
English descriptors
- KwdEn :
Abstract
In order to determine whether, besides the severe striatal dopamine (DA) loss, other brain neurotransmitter changes may be a constant biochemical feature of idiopathic Parkinson's disease (iPD), we measured the concentration of the three major brain monoamines noradrenaline (NA), DA, and serotonin (5-HT) and their metabolites in five rostro-caudal subdivisions of the hypothalamus of eight control patients and nine patients with morphologically confirmed iPD. In the whole hypothalamus of the iPD patients we found a mild to moderate mean reduction of NA(−52%, P < 0.05),DA(−25%),and5-HT(−26%). At the subregional level, the most consistently affected area was the intermediate subdivision of the hypothalamus proper where all three monoamines were statistically significantly reduced. Evaluation of individual patient values indicated that, in contrast to the constant and severe DA reduction present in putamen of each of the iPD patients (DA loss ranging from 96% to 99%), several of these patients had whole (and subregional) hypothalamic monoamine values well within the range of controls. We conclude that, although possibly involved in autonomic and/or endocrine disturbances in some patients with iPD, none of the observed monoamine changes in the hypothalamus is an obligatory feature of iPD. Our study demonstrates the need for evaluation of individual patient values rather than mean differences in order to permit valid conclusions to be drawn as to whether an observed neurochemical change can be regarded as specific to a given brain disorder.
Url:
DOI: 10.1016/0006-8993(94)91761-2
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects</title><author><name sortKey="Shannak, K" sort="Shannak, K" uniqKey="Shannak K" first="K." last="Shannak">K. Shannak</name></author><author><name sortKey="Rajput, A" sort="Rajput, A" uniqKey="Rajput A" first="A." last="Rajput">A. Rajput</name></author><author><name sortKey="Rozdilsky, B" sort="Rozdilsky, B" uniqKey="Rozdilsky B" first="B." last="Rozdilsky">B. Rozdilsky</name></author><author><name sortKey="Kish, S" sort="Kish, S" uniqKey="Kish S" first="S." last="Kish">S. Kish</name></author><author><name sortKey="Gilbert, J" sort="Gilbert, J" uniqKey="Gilbert J" first="J." last="Gilbert">J. Gilbert</name></author><author><name sortKey="Hornykiewicz, O" sort="Hornykiewicz, O" uniqKey="Hornykiewicz O" first="O." last="Hornykiewicz">O. Hornykiewicz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4102B406468C0B6BA9172B93AD50607D80772547</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1016/0006-8993(94)91761-2</idno><idno type="url">https://api.istex.fr/document/4102B406468C0B6BA9172B93AD50607D80772547/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000C70</idno><idno type="wicri:Area/Main/Curation">000B16</idno><idno type="wicri:Area/Main/Exploration">002419</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects</title><author><name sortKey="Shannak, K" sort="Shannak, K" uniqKey="Shannak K" first="K." last="Shannak">K. Shannak</name><affiliation><wicri:noCountry code="subField">CanadaM5T 1R8</wicri:noCountry></affiliation></author><author><name sortKey="Rajput, A" sort="Rajput, A" uniqKey="Rajput A" first="A." last="Rajput">A. Rajput</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>University of Saskatoon, Saskatoon, Sask.</wicri:regionArea><wicri:noRegion>Sask.</wicri:noRegion></affiliation></author><author><name sortKey="Rozdilsky, B" sort="Rozdilsky, B" uniqKey="Rozdilsky B" first="B." last="Rozdilsky">B. Rozdilsky</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>University of Saskatoon, Saskatoon, Sask.</wicri:regionArea><wicri:noRegion>Sask.</wicri:noRegion></affiliation></author><author><name sortKey="Kish, S" sort="Kish, S" uniqKey="Kish S" first="S." last="Kish">S. Kish</name><affiliation><wicri:noCountry code="subField">CanadaM5T 1R8</wicri:noCountry></affiliation></author><author><name sortKey="Gilbert, J" sort="Gilbert, J" uniqKey="Gilbert J" first="J." last="Gilbert">J. Gilbert</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Victoria Hospital, London, Ont.</wicri:regionArea><wicri:noRegion>Ont.</wicri:noRegion></affiliation></author><author><name sortKey="Hornykiewicz, O" sort="Hornykiewicz, O" uniqKey="Hornykiewicz O" first="O." last="Hornykiewicz">O. Hornykiewicz</name><affiliation><wicri:noCountry code="subField">CanadaM5T 1R8</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Brain Research</title><title level="j" type="abbrev">BRES</title><idno type="ISSN">0006-8993</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1993">1993</date><biblScope unit="volume">639</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="33">33</biblScope><biblScope unit="page" to="41">41</biblScope></imprint><idno type="ISSN">0006-8993</idno></series><idno type="istex">4102B406468C0B6BA9172B93AD50607D80772547</idno><idno type="DOI">10.1016/0006-8993(94)91761-2</idno><idno type="PII">0006-8993(94)91761-2</idno><idno type="ArticleID">94917612</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0006-8993</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine</term><term>Hypothalamus</term><term>Monoamine</term><term>Noradrenaline</term><term>Parkinson's disease</term><term>Serotonin</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In order to determine whether, besides the severe striatal dopamine (DA) loss, other brain neurotransmitter changes may be a constant biochemical feature of idiopathic Parkinson's disease (iPD), we measured the concentration of the three major brain monoamines noradrenaline (NA), DA, and serotonin (5-HT) and their metabolites in five rostro-caudal subdivisions of the hypothalamus of eight control patients and nine patients with morphologically confirmed iPD. In the whole hypothalamus of the iPD patients we found a mild to moderate mean reduction of NA(−52%, P < 0.05),DA(−25%),and5-HT(−26%). At the subregional level, the most consistently affected area was the intermediate subdivision of the hypothalamus proper where all three monoamines were statistically significantly reduced. Evaluation of individual patient values indicated that, in contrast to the constant and severe DA reduction present in putamen of each of the iPD patients (DA loss ranging from 96% to 99%), several of these patients had whole (and subregional) hypothalamic monoamine values well within the range of controls. We conclude that, although possibly involved in autonomic and/or endocrine disturbances in some patients with iPD, none of the observed monoamine changes in the hypothalamus is an obligatory feature of iPD. Our study demonstrates the need for evaluation of individual patient values rather than mean differences in order to permit valid conclusions to be drawn as to whether an observed neurochemical change can be regarded as specific to a given brain disorder.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Hornykiewicz, O" sort="Hornykiewicz, O" uniqKey="Hornykiewicz O" first="O." last="Hornykiewicz">O. Hornykiewicz</name><name sortKey="Kish, S" sort="Kish, S" uniqKey="Kish S" first="S." last="Kish">S. Kish</name><name sortKey="Shannak, K" sort="Shannak, K" uniqKey="Shannak K" first="K." last="Shannak">K. Shannak</name></noCountry><country name="Canada"><noRegion><name sortKey="Rajput, A" sort="Rajput, A" uniqKey="Rajput A" first="A." last="Rajput">A. Rajput</name></noRegion><name sortKey="Gilbert, J" sort="Gilbert, J" uniqKey="Gilbert J" first="J." last="Gilbert">J. Gilbert</name><name sortKey="Rozdilsky, B" sort="Rozdilsky, B" uniqKey="Rozdilsky B" first="B." last="Rozdilsky">B. Rozdilsky</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002419 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002419 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4102B406468C0B6BA9172B93AD50607D80772547
|texte= Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects
}}
| This area was generated with Dilib version V0.6.23. |  |